HiCrome™ UTI Agar, Modified

As low as ₹2,378.00
Availability: In stock
Only %1 left
SKU:
M1418
A chromogenic differential medium for identification, differentiation and confirmation of enteric bacteria especially Proteus species as well as potentially pathogenic gram-positive organisms.


Intended use:

Recommended for identification, differentiation and confirmation of enteric bacteria from specimens such as urine which may contain large number of Proteus species as well as potentially pathogenic gram-positive organisms.

Composition**

Ingredients g/L
Peptone 18.000
Tryptone 4.000
HM Peptone B# 6.000
Chromogenic mixture 12.440
Agar 15.000

Final pH (at 25°C): 7.2±0.2

**Formula adjusted, standardized to suit performance parameters

# -Equivalent to Beef extract

Directions

Suspend 55.44 gram in 1000 ml purified/distilled water. Heat to boiling to dissolve the medium completely. Sterilize by autoclaving at 15 lbs pressure (121°C) for 15 minutes. Cool to 45-50°C. Mix well and pour into sterile Petri plates.

Principle And Interpretation

HiCrome™ UTI Agar, Modified is formulated on the basis of work carried out by Pezzlo (1), Wilkie et al (2), Friedman et al (3), Murray et al (4), Soriano and Ponte (5) and Merlino et al (6). These media is the modification of HiCrome™ UTI Agar (M1353), which can be used in place of MacConkey Agar for isolation and confirmation of various microorganisms. It facilitates and expedites the identification of some gram-negative bacteria and some gram-positive bacteria on the basis of different contrasted colony colours produced by reactions of genus or species specific enzymes with two chromogenic substrates.

Enzymes produced by Enterococcus species, Escherichia coli and coliforms cleave the chromogenic substrates incorporated in the medium. Presence of rich source of phenylalanine and tryptophan from peptone and tryptone provides an indication of tryptophan deaminase activity, revealed with TDA Reagent (R036) indicating the presence of Proteus species, Morganella species and Providencia species, which appear brown. One chromogenic substrate is cleaved by β-glucosidase possessed by Enterococci resulting in formation of blue colonies. E.coli produce purple-magenta colonies due to the enzyme β-D-galactosidase which cleaves the other chromogenic substrate. Further confirmation of E.coli can be done by performing indole test using DMACA Reagent (R035). Also, some strains of Enterobacter cloacae lacking β-glucosidase show pink-colonies indistinguishable from E.coli. The DMACA reagent for indole test (should be performed on filter paper) distinguishes between E.coli and Enterobacter, and also between Proteus mirabilis and other species. Coliforms produce purple coloured colonies due to cleavage of both the chromogenic substrates Peptone, HM Peptone B and tryptone provides nitrogenous, carbonaceous compounds and other essential growth nutrients.

Type of specimen

Clinical samples : urine, faeces, etc.; Food samples; Water samples.

Specimen Collection and Handling

For clinical samples follow appropriate techniques for handling specimens as per established guidelines (7,8).

For food and dairy samples, follow appropriate techniques for sample collection and processing as per guidelines (9,10). For water samples, follow appropriate techniques for sample collection, processing as per guidelines and local standards (11).

After use, contaminated materials must be sterilized by autoclaving before discarding.

Warning and Precautions

In Vitro diagnostic use. For professional use only. Read the label before opening the container. Wear protective gloves/protective clothing/eye protection/face protection. Follow good microbiological lab practices while handling specimens and culture. Standard precautions as per established guidelines should be followed while handling clinical specimens. Safety guidelines may be referred in individual safety data sheets.

Limitations

  1. Since it is an enzyme-substrate based reaction, the intensity of colour may vary with isolates.
  2. Further biochemical and serological test must be carried out for confirmation.

Performance and Evaluation

Performance of the medium is expected when used as per the direction on the label within the expiry period when stored at recommended temperature.

Quality Control

Appearance

Cream to yellow homogeneous free flowing powder

Gelling

Firm, comparable with 1.5% Agar gel

Colour and Clarity of prepared medium

Light amber coloured, clear to slightly opalescent gel forms in Petri plates

Reaction

Reaction of 5.54% w/v aqueous solution at 25°C. pH : 7.2±0.2

pH

7.00-7.40

Cultural Response

Cultural characteristics observed after an incubation at 35-37°C for 24 hours.

Organism Inoculum (CFU) Growth Recovery Colour of Colony TDA (add 1-2 drops of TDA reagent) DMACA (transfer colony on filter paper dipped in DMACA Reagent)
Escherichia coli ATCC 25922 (00013*) 50-100 luxuriant >=70% Purple to magenta negative reaction positive reaction, formation of blue purple colour around growth
Enterococcus faecalis ATCC 29212 (00087*) 50-100 luxuriant >=70% blue-green (small) negative reaction negative reaction
Klebsiella pneumoniae ATCC 13883 (00097*) 50-100 luxuriant >=70% blue to purple, mucoid negative reaction negative reaction
Proteus mirabilis ATCC 12453 50-100 luxuriant >=70% light brown positive reaction, development of brown colouration negative reaction
Pseudomonas aeruginosa ATCC 27853 (00025*) 50-100 luxuriant >=70% colourless (greenish pigment may be observed) negative reaction negative reaction
Staphylococcus aureus subsp. aureus ATCC 25923 (00034*) 50-100 luxuriant >=70% golden yellow negative reaction negative reaction

Key : (*) Corresponding WDCM numbers.

Storage and Shelf Life

Store between 15-25°C in a tightly closed container and the prepared medium at 2-8°C. Use before expiry date on the label. On opening, product should be properly stored dry, after tightly capping the bottle in order to prevent lump formation due to the hygroscopic nature of the product. Improper storage of the product may lead to lump formation. Store in dry ventilated area protected from extremes of temperature and sources of ignition Seal the container tightly after use. Product performance is best if used within stated expiry period.

Disposal

User must ensure safe disposal by autoclaving and/or incineration of used or unusable preparations of this product. Follow established laboratory procedures in disposing of infectious materials and material that comes into contact with clinical sample must be decontaminated and disposed of in accordance with current laboratory techniques (7,8).

Reference

  1. Pezzlo M, (1998), Clinical Microbiology Reviews, 1:268-280
  2. Wilkie M.E., Almond M.K. and Marsh F.P., (1992), British Medical Journal, 305:1137-1141.
  3. Friedman M.P. et al. (1991), Journal of Clinical Microbiology, 29:2385-2389.
  4. Murray P., Traynor P. and Hopson D., (1992), Journal of Clinical Microbiology, 30:1600-1601.
  5. Soriano F. and Ponte C., (1992), Journal of Clinical Microbiology, 30:3033-3034.
  6. Merlino et al. (1995), Abstr. Austr. Microbiol., 16(4):17-3.
  7. Isenberg, H.D. Clinical Microbiology Procedures Handbook 2nd Edition.
  8. Jorgensen, J.H., Pfaller, M.A., Carroll, K.C., Funke, G., Landry, M.L., Richter, S.S and Warnock., D.W. (2015) Manual of Clinical Microbiology, 11th Edition. Vol. 1.
  9. Salfinger Y., and Tortorello M.L., 2015, Compendium of Methods for the Microbiological Examination of Foods, 5th Ed., American Public Health Association, Washington, D.C.
  10. Wehr H. M. and Frank J. H., 2004, Standard Methods for the Microbiological Examination of Dairy Products, 17th Ed., APHA Inc., Washington, D.C.
  11. Lipps WC, Braun-Howland EB, Baxter TE, eds. Standard methods for the Examination of Water and Wastewater, 24th ed. Washington DC:APHA Press; 2023.
More Information
Product Name HiCrome™ UTI Agar, Modified
SKU M1418
Product Type HiCrome™
Physical Form Powder
Origin Animal
Packaging type HDPE
References 1.Baird R.B., Eaton A.D., and Rice E.W., (Eds.), 2015, Standard Methods for the Examination of Water and Wastewater, 23rd ed., APHA, Washington, D.C. 2.Friedman M.P. et al. (1991), Journal of Clinical Microbiology, 29:2385-2389.3.Isenberg, H.D. Clinical Microbiology Procedures Handbook 2nd Edition.4.Jorgensen,J.H., Pfaller, M.A., Carroll, K.C., Funke, G., Landry, M.L., Richter, S.S and Warnock., D.W. (2015) Manual of Clinical Microbiology, 11th Edition. Vol. 1. 5.Merlino et al. (1995), Abstr. Austr. Microbiol., 16(4):17-3 6.Murray P., Traynor P. and Hopson D., (1992), Journal of Clinical Microbiology, 30:1600-1601. 7.Pezzlo M, (1998), Clinical Microbiology Reviews, 1:268-280 8.Salfinger Y., and Tortorello M.L.,2015, Compendium of Methods for the Microbiological Examination of Foods,5th Ed., American Public Health Association, Washington, D.C. 9.Soriano F. and Ponte C., (1992), Journal of Clinical Microbiology, 30:3033-3034 10.Wehr H. M. and Frank J. H., 2004, Standard Methods for the Microbiological Examination of Dairy Products, 17th Ed., APHA Inc., Washington, D.C. 11.Wilkie M.E., Almond M.K. and Marsh F.P., (1992), British Medical Journal, 305:1137-1141.
Customized Product Available No
Write Your Own Review
You're reviewing:HiCrome™ UTI Agar, Modified
Your Rating

Upsell Products